Fosun International Ltd

Q2 2022 13F Holdings Report, Stock Holdings

Signature - Title
Angel Sze - Company Secretary
Location
Hong Kong
Holdings as of
June 30, 2022
Value $
$625M
Num holdings
64
Date filed
8/10/2022, 08:36 AM
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included BNTX, AMRX, VRAYQ, BFLY, and NATR.
Previous filing
Q1 2022 - May 11, 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2022 Q2 compared to 2022 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Angel Sze Company Secretary Hong Kong, Hong Kong 8/10/2022

This Form 13F does not include the Section 13(f) securities held by Hauck & Aufhaeuser Fund Services S.A. as it determines that it exercises no investment discretion over such Section 13(f) securities as of June 30, 2022.

Other Included Managers (3):

Num Name Location File Number
1 Fidelidade-Companhia de Seguros, S.A. Lisboa, Portugal 028-16288
2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Shanghai, China 028-18303
3 Ameritrust Group, Inc. Southfield, MI 028-20162